期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Pediatric living donor liver transplantation decade progress in Shanghai:Characteristics and risks factors of mortality 被引量:5
1
作者 zhi-ying pan Yi-Chen Fan +9 位作者 Xiao-Qiang Wang Ling-Ke Chen Qiao-Qun Zou Tao Zhou Bi-Jun Qiu Ye-Feng Lu Cong-Huan Shen Wei-Feng Yu Yi Luo Dian-San Su 《World Journal of Gastroenterology》 SCIE CAS 2020年第12期1352-1364,共13页
BACKGROUND Pediatric living donor liver transplantation(LDLT) has become the gold standard for patients with end-stage liver disease. With improvements in organ preservation, immunosuppression, and surgical and anesth... BACKGROUND Pediatric living donor liver transplantation(LDLT) has become the gold standard for patients with end-stage liver disease. With improvements in organ preservation, immunosuppression, and surgical and anesthesia techniques, the survival rates and long-term outcomes of patients after LDLT have significantly improved worldwide. However, data on anesthetic management and postoperative survival rate of pediatric LDLT in China are rare.AIM To review the status of pediatric LDLT in Shanghai and investigate the factors related to anesthetic management and survival rate in pediatric LDLT.METHODS We conducted a retrospective observational study to investigate the status of pediatric LDLT in Shanghai by reviewing 544 records of patients who underwent pediatric LDLT since the first operation on October 21, 2006 until August 10, 2016 at Renji Hospital and Huashan Hospital.RESULTS The 30-d, 90-d, 1-year, and 2-year survival rates were 95.22%, 93.38%, 91.36%,and 89.34%, respectively. The 2-year patient survival rate after January 1, 2011 significantly improved compared with the previous period(74.47% vs 90.74%;hazard ratio: 2.92;95% confidence interval(CI): 2.16–14.14;P = 0.0004). Median duration of mechanical ventilation in the intensive care unit(ICU) was 18 h [interquartile range(IQR), 15.25–20.25], median ICU length of stay was 6 d(IQR:4.80–9.00), and median postoperative length of stay was 24 d(IQR: 18.00–34.00).Forty-seven(8.60%) of 544 patients did not receive red blood cell transfusion during the operation.CONCLUSION Pediatric end-stage liver disease score, anesthesia duration, operation duration,intraoperative blood loss, and ICU length of stay were independent predictive factors of in-hospital patient survival. Pediatric end-stage liver disease score,operation duration, and ICU length of stay were independent predictive factors of 1-year and 3-year patient survival. 展开更多
关键词 Living DONOR Liver TRANSPLANTATION ANESTHESIA Survival PEDIATRIC OUTCOME
下载PDF
Association of different central venous pressure levels with outcome of living-donor liver transplantation in children under 12 years 被引量:1
2
作者 Yi-Chen Fan Xiao-Qiang Wang +4 位作者 Dan-Yan Zhu Xiao-Rong Huai Wei-Feng Yu Dian-San Su zhi-ying pan 《World Journal of Pediatrics》 SCIE CAS CSCD 2023年第2期170-179,共10页
Background Pediatric liver transplantation is an important modality for treating biliary atresia.The overall survival(OS)rate of pediatric liver transplantation has significantly improved compared with that of 20 year... Background Pediatric liver transplantation is an important modality for treating biliary atresia.The overall survival(OS)rate of pediatric liver transplantation has significantly improved compared with that of 20 years ago,but it is still unsatisfactory.The anesthesia strategy of maintaining low central venous pressure(CVP)has shown a positive effect on prognosis in adult liver transplantation.However,this relationship remains unclear in pediatric liver transplantation.Thus,this study was conducted to review the data of pediatric living-donor liver transplantation to analyze the associations of different CVP levels with the prognosis of recipients.Methods This was a retrospective study and the patients were divided into two groups according to CVP levels after abdominal closure:low CVP(LCVP)(≤10 cmH2O,n=470)and high CVP(HCVP)(>10 cmH2O,n=242).The primary outcome measured in the study was the overall survival rate.The secondary outcomes included the duration of mechanical ventilation in the intensive care unit(ICU),length of stay in the ICU,and postoperative stay in the hospital.Patient demographic and perioperative data were collected and compared between the two groups.Kaplan-Meier curves were constructed to determine the associations of different CVP levels with the survival rate.Results In the study,712 patients,including 470 in the LCVP group and 242 in the HCVP group,were enrolled.After propensity score matching,212 pairs remained in the group.The LCVP group showed a higher overall survival rate than the HCVP group in the Kaplan-Meier curves and multivariate Cox regression analyses(P=0.018),and the HCVP group had a hazard ratio of 2.445(95%confidence interval,1.163–5.140).Conclusion This study confirmed that a low-CVP level at the end of surgery is associated with improved overall survival and a shorter length of hospital stay. 展开更多
关键词 Central venous pressure General anesthesia Overall survival rate Pediatric living-donor liver transplantation PROGNOSIS
原文传递
生物类似药证据链完备性的合成P值法评估(英文)
3
作者 zhi-ying pan Nan Zhang +2 位作者 Yao Yu Eric Chi Shein-chung Chow 《药物分析杂志》 CAS CSCD 北大核心 2015年第5期832-836,共5页
最近几年,许多生物制药/生物技术公司对研发生物类似药物的兴趣越来越强。根据生物类似药物的研发需求,美国药监局(FDA)在2012年颁布了3个相关指导原则草案。FDA在这3个指导原则中表示,对于生物类似药物的注册申请的全部提交资料采用&qu... 最近几年,许多生物制药/生物技术公司对研发生物类似药物的兴趣越来越强。根据生物类似药物的研发需求,美国药监局(FDA)在2012年颁布了3个相关指导原则草案。FDA在这3个指导原则中表示,对于生物类似药物的注册申请的全部提交资料采用"证据链完备性(totality-of-the-evidence)"的方法来审查,并鼓励研发企业使用"逐步递进法stepwise"来找出与原研产品相比,仿制生物制品在每一工艺步骤中的残余不确定度,进而在后续的研发步骤中设法解决这些残余不确定度。尽管要获得"具有较小不确定度的充足证据链完备性"这样的概念可以理解,但是,如何根据提交的所有注册申请信息客观地评价"证据链完备性",以及如何基于已有信息确定下一步研发步骤的程度和范围仍然是需解决的具体操作问题。本研究探索了费舍尔合成P值的概念(Fisher,1932)在等效性检验设置中的应用,更具体地说,在一个生物类似药物的临床研究中,根据"逐步递进法"和"临床证据完备性"的概念,用它来设计和分析2个生物类似药物的临床相似性。 展开更多
关键词 生物相似性 证据链完备性 逐步法方式 合成P值法 P值的权重总和法 Fisher法 等效性检验
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部